Anthropic launches the Anthropic Institute to study AI’s impact on jobs, governance, and security as the company warns rapid advances could reshape society.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

A fully autonomous AI agent has claimed the top of HackerOne’s bug bounty leaderboard – and this month it submitted a CVSS 9.8 remote code execution flaw to Microsoft via HackerOne that the company ...